Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Novel Model Combining Circulating Absolute Monocyte Counts and a Four-Gene Monocyte Signature in Leukapheresis Identifies Lymphoma Patients at Very High Risk of Progression after Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

Cristiana Carniti, Martina Magni, Nicole Caldarelli, Tommaso Torelli, Luca Agnelli, Eugenio Fardella, Daniele Lorenzini, Arianna Rigamonti, Sadhana Jonnalagadda, Giada Zanirato, Anisa Bermema, Silvia Brich, Anna Dodero, Annalisa Chiappella, Paolo Corradini

Blood (2023) 142 (Supplement 1): 4873.

https://doi.org/10.1182/blood-2023-188416

Published: 2023

Journal Articles

Tisagenlecleucel and Axicabtagene Ciloleucel Expansion Kinetics and CAR T Cell Attributes in the Infusion Products Are Early Predictors of Clinical Efficacy

Cristiana Carniti, Chiara Monfrini, Vanessa Aragona, Martina Magni, Cristina Vella, Eugenio Fardella, Riccardo Betta, Anisa Bermema, Federico Stella, Anna Dodero, Annalisa Chiappella, Anna Guidetti, Paolo Corradini

Blood (2021) 138 (Supplement 1): 3877.

https://doi.org/10.1182/blood-2021-152309

Published: 2021

Journal Articles

Disease Monitoring in Multiple Myeloma Patients Using Liquid Biopsy and Next Generation Sequencing of IGH Gene Rearrangements

Silvia Gimondi, Giulia Biancon, Antonio Vendramin, Silvia Zaninelli, Sara Rizzitano, Sofia Cannara Malan, Anisa Bermema, Vittorio Montefusco, Cristiana Carniti, Paolo Corradini

Blood (2016) 128 (22): 4430.

https://doi.org/10.1182/blood.V128.22.4430.4430

Published: 2016

Journal Articles

Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients

Silvia Gimondi, Alessandra Cavanè, Antonio Vendramin, Biancon Giulia, Anisa Bermema, Vittorio Montefusco, Paolo Corradini, Cristiana Carniti

Blood (2015) 126 (23): 2987.

https://doi.org/10.1182/blood.V126.23.2987.2987

Published: 2015

Journal Articles

Pharmacologic Inhibition of JAK1/JAK2 Signaling Protects from Acute GvHD While Preserving Gvt in Mice

Cristiana Carniti, Silvia Gimondi, Antonio Vendramin, Camilla Recordati, DVM, PhD Dipl. ECVP, Davide Confalonieri, Anisa Bermema, Paolo Corradini, MD, Jacopo Mariotti, MD

Blood (2014) 124 (21): 1107.

https://doi.org/10.1182/blood.V124.21.1107.1107

Published: 2014

Journal Articles

In Vivo Jak1/Jak2 Inhibition Protects From Acute GvHD While Maintaining Robust Anti-Tumor Activity

Cristiana Carniti, Silvia Gimondi, Antonio Vendramin, Davide Confalonieri, Camilla Recordati, DVM, PhD, Dipl. ECVP, Anisa Bermema, Jacopo Mariotti, Paolo Corradini

Blood (2013) 122 (21): 4481.

https://doi.org/10.1182/blood.V122.21.4481.4481

Published: 2013

Journal Articles

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

Cristiana Carniti, PhD, Silvia Gimondi, Raffaella Vaccaroli, Antonio Vendramin, PhD, Anisa Bermema, Enrico Radaelli, DVM, PhD, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 2997.

https://doi.org/10.1182/blood.V120.21.2997.2997

Published: 2012

Journal Articles

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

Cristiana Carniti, PhD, Antonio Vendramin, PhD, Silvia Gimondi, Anisa Bermema, Fabiana Riva, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 1898.

https://doi.org/10.1182/blood.V120.21.1898.1898

Published: 2012

Journal Articles

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

Cristiana Carniti, PhD, Silvia Gimondi, Davide Lucini, Jacopo Mariotti, MD, Anisa Bermema, Antonio Vendramin, Mara Morelli, MD, Chiara Formica, Paolo Corradini, MD

Blood (2011) 118 (21): 311.

https://doi.org/10.1182/blood.V118.21.311.311

Published: 2011

Journal Articles

Analysis of Circulating Microrna Expression Profile In Patients Transplanted From Matched Unrelated Donors (MUD) Identifies mir203 as a Putative Marker of aGVHD

Cristiana Carniti, PhD, Silvia A Gimondi, Anisa Bermema, Antonio Vendramin, Mara Morelli, Paolo Corradini, MD

Blood (2010) 116 (21): 2308.

https://doi.org/10.1182/blood.V116.21.2308.2308

Published: 2010

Journal Articles

Impact of Minor Histocompatibility Antigens (mHAg) Mismatches On Gvhd Incidence in Non-Myeloablative or Reduced Intensity Allogeneic Stem Cell Transplantation.

Cristiana Carniti, PhD, Francesco Spina, MD, Antonio Vendramin, PhD, Simona Di Terlizzi, Anna Raganato, PhD, Anisa Bermema, Paolo Corradini, MD

Blood (2009) 114 (22): 4494.

https://doi.org/10.1182/blood.V114.22.4494.4494

Published: 2009

NARROW

A Novel Model Combining Circulating Absolute Monocyte Counts and a Four-Gene Monocyte Signature in Leukapheresis Identifies Lymphoma Patients at Very High Risk of Progression after Tisagenlecleucel or Axicabtagene Ciloleucel Therapy

Tisagenlecleucel and Axicabtagene Ciloleucel Expansion Kinetics and CAR T Cell Attributes in the Infusion Products Are Early Predictors of Clinical Efficacy

Disease Monitoring in Multiple Myeloma Patients Using Liquid Biopsy and Next Generation Sequencing of IGH Gene Rearrangements

Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients

Pharmacologic Inhibition of JAK1/JAK2 Signaling Protects from Acute GvHD While Preserving Gvt in Mice

In Vivo Jak1/Jak2 Inhibition Protects From Acute GvHD While Maintaining Robust Anti-Tumor Activity

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

Analysis of Circulating Microrna Expression Profile In Patients Transplanted From Matched Unrelated Donors (MUD) Identifies mir203 as a Putative Marker of aGVHD

Impact of Minor Histocompatibility Antigens (mHAg) Mismatches On Gvhd Incidence in Non-Myeloablative or Reduced Intensity Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only